| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $94.5M | -6.8% |
| R&D Expense | $5.3M | -0.6% |
| SG&A Expense | $70.3M | +26.9% |
| Operating Income | -$40.1M | -538.4% |
| Interest Expense | $6.3M | +583.4% |
| Pre-tax Income | -$53.5M | -4920.4% |
| Income Tax | -$780K | -166.4% |
| Net Income | -$52.7M | — |
| EPS (Basic) | -$1.08 | — |
| EPS (Diluted) | -$1.08 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.4M | +5240.0% |
| Accounts Receivable | $1.6M | -20.2% |
| Inventory | $15.7M | -31.0% |
| Current Assets | $35.2M | +4002.8% |
| Total Assets | $74.9M | -67.8% |
| Current Liabilities | $53.7M | +4012.6% |
| Total Liabilities | $148.0M | +1492.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.6M | -24.4% |
| Capital Expenditures | $1.6M | -11.2% |
| Investing Cash Flow | -$2.4M | +77.1% |
| Financing Cash Flow | $39.8M | +97.0% |
| Free Cash Flow | -$28.2M | -21.7% |
| Stockholders' Equity |
| -$73.0M |
| -766.9% |